The high price often associated with prescription drugs can make it hard to comply with a doctor’s directives for some patients. Many health conditions demand patients stay on a prescribed...
Learn MoreThe injectables drugs market was USD 331 billion in the year 2015. However, with the increasing number of chronic diseases such as diabetes, cancer, etc., the need for such injections...
Learn MoreIn May, the DTAB (Drugs Technical Advisory Board) gave a green flag to the recommendation for amending the Drugs & Cosmetics Act. This makes pharmaceutical marketing firms in Latin America...
Learn MoreThe demand for generic Medicine / Drugs is increasing in Latin America, and Indian pharmaceutical companies realize this opportunity’s great potential. Efficient and affordable medicines are always required, making this...
Learn MoreThe development of a new medicine is a complex task and requires many iteration and decisions before a commercial launch. Some biotech and pharmaceutical companies in Latin America choose to...
Learn MoreThe India-Latin America economic relationship has evolved hugely over the past decade, with new investments and value-added businesses that add value to the large trade in commodities. India and Latin...
Learn MoreThe Latin American pharmaceutical contract manufacturing organization market is expected to register a CAGR of 3.3% between 2020 and 2025. Over the years, the demand for Pharma tablets and capsules...
Learn MoreLatin America is becoming a land of opportunity for many emerging markets, and food supplements are rapidly becoming popular in the LATAM region. This Latin America’s Nutraceutical market is worth...
Learn MoreNowadays, as diseases are increasing at a fast rate, so is the need for a Global supplier of pharmaceuticals and drugs in the USA along with the Indian pharmaceuticals providers...
Learn MoreMost industry observers expect that Indian pharma exports to the US will increase again. But, Indian companies have – in the meantime – been rapidly increasing their efforts to build stronger footprints in strategic emerging markets such as Russia, Brazil, and some Asian and African countries.
Learn More